Inventor · disambiguated record
Peter Pechan
Also filed as: PECHAN PETER
8 granted patents·7 pending applications·41 citations·filing 2007–2022
84Inventor score
Top patents by PatentIndex Score
15 records- 0192US7928072B2Multimeric constructsGENZYME CORP·Filed 2007·Granted Apr 19, 2011·21 cites·35 claims
- 0289US10183983B2Nucleic acids encoding fusion proteins comprising PDGF and VEGF binding portions and methods of using thereofGENZYME CORP·Filed 2017·Granted Jan 22, 2019·7 cites·8 claims
- 0387US9637534B2Fusion proteins comprising PDGF and VEGF binding portions and methods of using thereofGENZYME CORP·Filed 2014·Granted May 2, 2017·8 cites·10 claims
- 0478US8658602B2Multimeric constructsSCARIA ABRAHAM·Filed 2011·Granted Feb 25, 2014·4 cites·28 claims
- 0572US9815892B2Multimeric constructsGENZYME CORP·Filed 2014·Granted Nov 14, 2017·1 cites·5 claims
- 0672US2022064262A1Fusion proteins comprising pdgf and vegf binding portions and methods of using thereofGENZYME CORP·Filed 2021·Application pending·0 cites
- 0767US11084864B2Fusion proteins comprising PDGF and VEGF binding portions and methods of using thereofGENZYME CORP·Filed 2018·Granted Aug 10, 2021·0 cites·21 claims
- 0864US2022340883A1USE OF iNOS INHIBITORS TO INCREASE VIRAL YIELD IN CULTUREGENZYME CORP·Filed 2022·Application pending·0 cites
- 0963US11299715B2Use of iNOS inhibitors to increase viral yield in cultureGENZYME CORP·Filed 2014·Granted Apr 12, 2022·0 cites·9 claims
- 1061US2024424141A1Aav particles comprising a liver-tropic capsid protein and alpha-galactosidase and their use to treat fabry diseaseCANBRIDGE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1159US2024191251A1Recombinant herpesvirales vectorSOLID BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1258US2018155417A1Multimeric constructsGENZYME CORP·Filed 2017·Application pending·0 cites
- 1353US2024261437A1Modified aav capsids and uses thereofSOLID BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1445US2022307052A1Recombinant herpesvirales vectorSOLID BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1541US10821193B2Adeno-associated viral vectors for treating myocilin (MYOC) glaucomaGENZYME CORP·Filed 2015·Granted Nov 3, 2020·0 cites·61 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →